Hypogonadotropic hypogonadism in a patient with morbid obesity
Related Experiment Video
Updated: Jul 10, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Miguel Angel Mollar Puchades1, Rosa Cámara Gómez, Maria Isabel del Olmo García
1Unit of Endocrinology, Universitary Hospital La Fe, Valencia, Spain. mimopu@comv.es
Abstract:
Obesity has recently become one of the most important public health problems. It is associated with a high rate of mortality, mainly because of cardiovascular disease, and can cause hormonal abnormalities such as hypogonadotropic hypogonadism. Weight loss is very beneficial for obese patients, because it results in improvement or even normalization of these conditions. In this report, we describe a morbidly obese patient with hypogonadotropic hypogonadism, which was probably caused by hyperprolactinemia and exacerbated by obesity-induced hormonal imbalances. After medical treatment for hyperprolactinemia and bariatric surgery, the patient's hormonal status became normal. Although morbid obesity can cause hypogonadotropic hypogonadism in men, the differential diagnosis should include other potential causes of hypogonadism if free testosterone levels are below normal.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Hypoglycemia and Glucagon
Hypothalamic-Pituitary Axis

